CHIN-HSIAO TSENGTIEN-SHANG HUANG2020-06-032020-06-0320050168-8227https://www.scopus.com/inward/record.uri?eid=2-s2.0-25444532528&doi=10.1016%2fj.diabres.2004.11.003&partnerID=40&md5=caf21a8158818568b4ff98eb6f325731https://scholars.lib.ntu.edu.tw/handle/123456789/496823[SDGs]SDG3glucose; hemoglobin A1c; high density lipoprotein cholesterol; low density lipoprotein cholesterol; pioglitazone; sulfonylurea; triacylglycerol; adult; aged; article; clinical article; clinical trial; comorbidity; controlled clinical trial; controlled study; coughing; diabetes control; double blind procedure; drug efficacy; drug safety; female; glucose blood level; human; lipoprotein blood level; liver toxicity; male; non insulin dependent diabetes mellitus; protein blood level; randomized controlled trial; triacylglycerol blood level; virus hepatitis; Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Lipids; Male; Middle Aged; Sulfonylurea Compounds; Taiwan; Thiazolidinedionesjournal article10.1016/j.diabres.2004.11.003161885792-s2.0-25444532528